Epigenetic targets in the diagnosis and treatment of prostate cancer
Prostate cancer (PC) is one of leading cause of cancer related deaths in men. Various aspects of cancer epigenetics are rapidly evolving and the role of 2 major epigenetic changes including DNA methylation and histone modifications in prostate cancer is being studied widely. The epigenetic changes are early event in the cancer development and are reversible. Novel epigenetic markers are being studied, which have the potential as sensitive diagnostic and prognostic marker. Variety of drugs targeting epigenetic changes are being studied, which can be effective individually or in combination with other conventional drugs in PC treatment. In this review, we discuss epigenetic changes associated with PC and their potential diagnostic and therapeutic applications including future areas of research.
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Digital revista |
| Language: | English |
| Published: |
Sociedade Brasileira de Urologia
2007
|
| Online Access: | http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1677-55382007000100003 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| id |
oai:scielo:S1677-55382007000100003 |
|---|---|
| record_format |
ojs |
| spelling |
oai:scielo:S1677-553820070001000032007-04-05Epigenetic targets in the diagnosis and treatment of prostate cancerManoharan,MurugesanRamachandran,KavithaSoloway,Mark S.Singal,Rakesh prostate cancer DNA methylation epigenesis/genetic Prostate cancer (PC) is one of leading cause of cancer related deaths in men. Various aspects of cancer epigenetics are rapidly evolving and the role of 2 major epigenetic changes including DNA methylation and histone modifications in prostate cancer is being studied widely. The epigenetic changes are early event in the cancer development and are reversible. Novel epigenetic markers are being studied, which have the potential as sensitive diagnostic and prognostic marker. Variety of drugs targeting epigenetic changes are being studied, which can be effective individually or in combination with other conventional drugs in PC treatment. In this review, we discuss epigenetic changes associated with PC and their potential diagnostic and therapeutic applications including future areas of research.info:eu-repo/semantics/openAccessSociedade Brasileira de UrologiaInternational braz j urol v.33 n.1 20072007-02-01info:eu-repo/semantics/articletext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S1677-55382007000100003en10.1590/S1677-55382007000100003 |
| institution |
SCIELO |
| collection |
OJS |
| country |
Brasil |
| countrycode |
BR |
| component |
Revista |
| access |
En linea |
| databasecode |
rev-scielo-br |
| tag |
revista |
| region |
America del Sur |
| libraryname |
SciELO |
| language |
English |
| format |
Digital |
| author |
Manoharan,Murugesan Ramachandran,Kavitha Soloway,Mark S. Singal,Rakesh |
| spellingShingle |
Manoharan,Murugesan Ramachandran,Kavitha Soloway,Mark S. Singal,Rakesh Epigenetic targets in the diagnosis and treatment of prostate cancer |
| author_facet |
Manoharan,Murugesan Ramachandran,Kavitha Soloway,Mark S. Singal,Rakesh |
| author_sort |
Manoharan,Murugesan |
| title |
Epigenetic targets in the diagnosis and treatment of prostate cancer |
| title_short |
Epigenetic targets in the diagnosis and treatment of prostate cancer |
| title_full |
Epigenetic targets in the diagnosis and treatment of prostate cancer |
| title_fullStr |
Epigenetic targets in the diagnosis and treatment of prostate cancer |
| title_full_unstemmed |
Epigenetic targets in the diagnosis and treatment of prostate cancer |
| title_sort |
epigenetic targets in the diagnosis and treatment of prostate cancer |
| description |
Prostate cancer (PC) is one of leading cause of cancer related deaths in men. Various aspects of cancer epigenetics are rapidly evolving and the role of 2 major epigenetic changes including DNA methylation and histone modifications in prostate cancer is being studied widely. The epigenetic changes are early event in the cancer development and are reversible. Novel epigenetic markers are being studied, which have the potential as sensitive diagnostic and prognostic marker. Variety of drugs targeting epigenetic changes are being studied, which can be effective individually or in combination with other conventional drugs in PC treatment. In this review, we discuss epigenetic changes associated with PC and their potential diagnostic and therapeutic applications including future areas of research. |
| publisher |
Sociedade Brasileira de Urologia |
| publishDate |
2007 |
| url |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1677-55382007000100003 |
| work_keys_str_mv |
AT manoharanmurugesan epigenetictargetsinthediagnosisandtreatmentofprostatecancer AT ramachandrankavitha epigenetictargetsinthediagnosisandtreatmentofprostatecancer AT solowaymarks epigenetictargetsinthediagnosisandtreatmentofprostatecancer AT singalrakesh epigenetictargetsinthediagnosisandtreatmentofprostatecancer |
| _version_ |
1756427992543789056 |